Stockholm, 171 77
Sweden
multiple sclerosis, covid-19, rituximabb
COVID, Interferon, virus, nasal spray, randomised controlled trial, respiratory virus, cancer, prevention
multiple sclerosis, treatment strategies, registries, disease modifying treatments